Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000108496608000022/abvv8kregardingauditors.htm
August 2011
June 2011
February 2009
September 2008
September 2008
August 2008
July 2008
June 2008
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000108496608000022/abvv8kregardingauditors.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Abviva Inc.
Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:
CIK: 1084966Events:
Form Type: 8-K Corporate News
Accession Number: 0001084966-08-000022
Submitted to the SEC: Tue Nov 18 2008 5:20:30 PM EST
Accepted by the SEC: Tue Nov 18 2008
Period: Monday, November 10, 2008
Industry: Medical Laboratories